Risankizumab Shows Durable GRAPPA Improvements for PsA
Consultant Live,
Risankizumab provided durable improvement in the signs and symptoms of psoriatic arthritis (PsA) across all Group for Research…
Risankizumab provided durable improvement in the signs and symptoms of psoriatic arthritis (PsA) across all Group for Research…
Risankizumab provided durable improvement in the signs and symptoms of psoriatic arthritis (PsA) across all Group for Research…
The most common symptoms of psoriatic arthritis (PsA) have a negative impact on patients’ quality of life, a new study shows…